Value proposition

AI-powered molecular modelling for accelerated and smarter drug development

biosimulytics is a deep-tech spin-out from University College Dublin’s School of Chemical & Bioprocess Engineering, founded in 2019.

We specialize in leveraging cutting-edge AI, advanced neural networks , molecular modeling, quantum technologies, and high-performance computing to accelerate the creation of new and improved therapies

What We Do:
🔍 Polymorphism Prediction: Tackling pharma’s major challenge by predicting API molecule arrangements.
🧪Structure-Based Drug Design (SBDD): Enhancing drug design with stable binding pose predictions.

🌍Proud EIC Accelerator participants since September 2023, EIT Innovation Team Award finalists, and now an EIT Digital portfolio company after completing the EIT Innovation Factory programme 2022-2023. Previously awarded Start-up of the Year at NovaUCD, we’re driven by innovation and excited to transform healthcare!